{"ticker": {"uuid": "55c7d89c-da8d-4227-a98a-95538f48f917", "symbol": "2696", "name": "Shanghai Henlius Biotech, Inc.", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Shanghai Henlius Biotech (SEHK:2696) Advances Cancer Trials, Is It A Bargain?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T04:01:51+00:00", "published_display": "11 Jul 2026 04:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Shanghai Henlius Biotech (SEHK:2696) Pricey Or Undervalued After Its Canada Denosumab Launch?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T11:55:41+00:00", "published_display": "02 Jul 2026 11:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Henlius Biotech (SEHK:2696) Valuation Check As HANBEIYOU Wins Key China Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQcURHMkdYZXgweTFIY2xxQUFNUlo3NXFXcEo1al9iRkNacGNKVndoa1U4N2ZJT19uQWdKdUZEZC1Db0xVU0xadGY2U2dYUXZGcGpheE9vQjNPckFJOTZuemlKMkhTOUUyNVBfN3FhWmo4aERjTnprRGo4amhRb3c4RWhNVGVrbUN2LWZ1MUpZelFScG94aGxxSjNsRlJsZXB5b1BhSU9B?oc=5", "source_name": "Market source", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fierce Pharma Asia\u2014Novartis' $5B Argo deal; Eisai's subcutaneous Leqembi nod; HKEX chastises Henlius", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQN0JmN0VUbmdSY1QtcDdJS2Q2WXV3WjllTktmV0pPcDRGemhwQUxUNEJoa0gtQXo2VWtZaHh4LVhwaHoyQzhCRndYeW80RVBYRGw3ZWp6X05nRXJQclYtVW8zcWRMd2RIcnlhQldTSnNLMWFiZjdLQjVxVGFLSEFBTERmMThZV0JtaWZvWkZ5TlZqYTFBTXgtdjVXV01ZZC0zZFdmWkdBNUEzSkwwU1gyeQ?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exchange\u2019s Disciplinary Action against Shanghai Henlius Biotech, Inc. (Stock Code: 2696) and One Former Director", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQMVo3RUxzbURpQUNxbzVsRm0tQ1RKUk5objFkbjZSUU9lZjVhR3pfVHBOenlMYTFrSkoyR2pFY01EdFpCS3pHd0ZqSFk2R1FBNWgzSTdhQXJEeXF0djNUcnB4NnVad1lKUlQtRVk1em93TUZGX1l0Q29HSEI1bVZzUUxHRXBxTEE?oc=5", "source_name": "hkex.com.hk", "published_at": "2025-09-02T07:00:00+00:00", "published_display": "02 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Henlius Biotech shareholders reject take-private offer from China's Fosun", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNQzNvVGlEUTRheEp4RGFvTUdkYzI0ZmRhUUZJRFV5TFlxV1dFSkt3a2d0NWZwRTRCd0ZTcjZTVG1CNUE1NHZCSkJtSFVVUmcwY2QwaTNOcVZPRExBeW9sanhrT2RHZ0hUcldhU1pYRlNXRGplWjlZSGVzN2RvR0dZU0hkLW14Z1VRcVFCLURqUE11LXlvOWZTTXBld29XUnZubDdkLW5BYzVBVWxEejJFYVR0U1BzWmJ3VXVGa1FTMDNTZ0JrQzlmX2NXbGlGYURWZDJWaWFn?oc=5", "source_name": "Reuters", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun's proposed Henlius Biotech buyout fails to pass shareholder vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZDI0dVRmVGtRMVNlMHJDNWRaSThwejRYWnFjc3NSUExjZmJLc3JYTFhtdmNXd2xocTRPS1lJdEIzenJVTHF3VFhWTlNaSml3NmxneDlkd0FUdGtVeHUzZ2hMMDhaTld5YjhsbURZRkVPUGpVTEJndjc0Uk5ydXptbTYtMDdMVl9KeTgzSE00M1VxTzRqZXAzalBwajdFUlBKLUF0Mzk5eXNXYjlwVlE?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai biotech firm\u2019s shares soar after Fosun\u2019s US$690 million buyout offer", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2024-06-25T07:00:00+00:00", "published_display": "25 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong-listed biotech firm Henlius edges closer to Star Market listing", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2020-08-31T07:00:00+00:00", "published_display": "31 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Biotech Unit Henlius Aims to Raise $477 Million in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQajE1THNEdVZkaHZFNkhQQV91U3Q1RVVyai0zTEhHcUhLV1d3X1VkTjhzdHVTSzRFM1BvZWVFZlctWDFVV3JQbWxTN3VZY0ZLUVNLRTA5ZTFaOU5nak9PNHJFX2VNSDVBREhLSFh0ZGNaTEtpVVd4VTIydGt4RU9paVhHWGZ3UTZOUTIyMzR2bVB1VVJibkNaTGtONzFfVzZCTHRrWWRxcU9XQmdZcncydVBiQWNzRDJKeEszT0FmTzd4UQ?oc=5", "source_name": "Caixin Global", "published_at": "2019-09-12T07:00:00+00:00", "published_display": "12 Sep 2019 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Shanghai Henlius Biotech (SEHK:2696) Advances Cancer Trials, Is It A Bargain?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T04:01:51+00:00", "published_display": "11 Jul 2026 04:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Shanghai Henlius Biotech (SEHK:2696) Pricey Or Undervalued After Its Canada Denosumab Launch?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T11:55:41+00:00", "published_display": "02 Jul 2026 11:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Henlius Biotech (SEHK:2696) Valuation Check As HANBEIYOU Wins Key China Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQcURHMkdYZXgweTFIY2xxQUFNUlo3NXFXcEo1al9iRkNacGNKVndoa1U4N2ZJT19uQWdKdUZEZC1Db0xVU0xadGY2U2dYUXZGcGpheE9vQjNPckFJOTZuemlKMkhTOUUyNVBfN3FhWmo4aERjTnprRGo4amhRb3c4RWhNVGVrbUN2LWZ1MUpZelFScG94aGxxSjNsRlJsZXB5b1BhSU9B?oc=5", "source_name": "Market source", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fierce Pharma Asia\u2014Novartis' $5B Argo deal; Eisai's subcutaneous Leqembi nod; HKEX chastises Henlius", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQN0JmN0VUbmdSY1QtcDdJS2Q2WXV3WjllTktmV0pPcDRGemhwQUxUNEJoa0gtQXo2VWtZaHh4LVhwaHoyQzhCRndYeW80RVBYRGw3ZWp6X05nRXJQclYtVW8zcWRMd2RIcnlhQldTSnNLMWFiZjdLQjVxVGFLSEFBTERmMThZV0JtaWZvWkZ5TlZqYTFBTXgtdjVXV01ZZC0zZFdmWkdBNUEzSkwwU1gyeQ?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exchange\u2019s Disciplinary Action against Shanghai Henlius Biotech, Inc. (Stock Code: 2696) and One Former Director", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQMVo3RUxzbURpQUNxbzVsRm0tQ1RKUk5objFkbjZSUU9lZjVhR3pfVHBOenlMYTFrSkoyR2pFY01EdFpCS3pHd0ZqSFk2R1FBNWgzSTdhQXJEeXF0djNUcnB4NnVad1lKUlQtRVk1em93TUZGX1l0Q29HSEI1bVZzUUxHRXBxTEE?oc=5", "source_name": "hkex.com.hk", "published_at": "2025-09-02T07:00:00+00:00", "published_display": "02 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Henlius Biotech shareholders reject take-private offer from China's Fosun", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNQzNvVGlEUTRheEp4RGFvTUdkYzI0ZmRhUUZJRFV5TFlxV1dFSkt3a2d0NWZwRTRCd0ZTcjZTVG1CNUE1NHZCSkJtSFVVUmcwY2QwaTNOcVZPRExBeW9sanhrT2RHZ0hUcldhU1pYRlNXRGplWjlZSGVzN2RvR0dZU0hkLW14Z1VRcVFCLURqUE11LXlvOWZTTXBld29XUnZubDdkLW5BYzVBVWxEejJFYVR0U1BzWmJ3VXVGa1FTMDNTZ0JrQzlmX2NXbGlGYURWZDJWaWFn?oc=5", "source_name": "Reuters", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun's proposed Henlius Biotech buyout fails to pass shareholder vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZDI0dVRmVGtRMVNlMHJDNWRaSThwejRYWnFjc3NSUExjZmJLc3JYTFhtdmNXd2xocTRPS1lJdEIzenJVTHF3VFhWTlNaSml3NmxneDlkd0FUdGtVeHUzZ2hMMDhaTld5YjhsbURZRkVPUGpVTEJndjc0Uk5ydXptbTYtMDdMVl9KeTgzSE00M1VxTzRqZXAzalBwajdFUlBKLUF0Mzk5eXNXYjlwVlE?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai biotech firm\u2019s shares soar after Fosun\u2019s US$690 million buyout offer", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2024-06-25T07:00:00+00:00", "published_display": "25 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong-listed biotech firm Henlius edges closer to Star Market listing", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2020-08-31T07:00:00+00:00", "published_display": "31 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Biotech Unit Henlius Aims to Raise $477 Million in Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQajE1THNEdVZkaHZFNkhQQV91U3Q1RVVyai0zTEhHcUhLV1d3X1VkTjhzdHVTSzRFM1BvZWVFZlctWDFVV3JQbWxTN3VZY0ZLUVNLRTA5ZTFaOU5nak9PNHJFX2VNSDVBREhLSFh0ZGNaTEtpVVd4VTIydGt4RU9paVhHWGZ3UTZOUTIyMzR2bVB1VVJibkNaTGtONzFfVzZCTHRrWWRxcU9XQmdZcncydVBiQWNzRDJKeEszT0FmTzd4UQ?oc=5", "source_name": "Caixin Global", "published_at": "2019-09-12T07:00:00+00:00", "published_display": "12 Sep 2019 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 10, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 9, "score": 51, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 4.75, "count": 8}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 62.9, "latest_week": "2026-07-10", "one_week_move": -5.7, "four_week_move": 0.5, "twelve_week_move": -25.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.756501, "market_dynamics_buy_signal": false, "relative_strength": -3.615059, "fair_value_gap": 68.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 58.5097, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.7% over one week, +0.5% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 2}, {"label": "Fierce Pharma", "count": 2}, {"label": "South China Morning Post", "count": 2}, {"label": "Market source", "count": 1}, {"label": "hkex.com.hk", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Caixin Global", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Regulatory and legal", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.7% over one week, +0.5% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Shanghai Henlius Biotech (SEHK:2696) Advances Cancer Trials, Is It A Bargain?"}], "updated_at": "2026-07-18T04:21:07.392834+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}